Jane Street’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.02M | Buy |
147,280
+96,103
| +188% | +$1.32M | ﹤0.01% | 2118 |
|
|
2025
Q1 | $566K | Buy |
51,177
+24,839
| +94% | +$275K | ﹤0.01% | 3781 |
|
|
2024
Q4 | $280K | Sell |
26,338
-4,380
| -14% | -$46.6K | ﹤0.01% | 4700 |
|
|
2024
Q3 | $390K | Sell |
30,718
-29,598
| -49% | -$376K | ﹤0.01% | 4581 |
|
|
2024
Q2 | $1.01M | Buy |
60,316
+37,899
| +169% | +$636K | ﹤0.01% | 3650 |
|
|
2024
Q1 | $336K | Buy |
22,417
+5,808
| +35% | +$87.1K | ﹤0.01% | 4504 |
|
|
2023
Q4 | $249K | Buy |
16,609
+6,552
| +65% | +$98.3K | ﹤0.01% | 4818 |
|
|
2023
Q3 | $141K | Sell |
10,057
-3,298
| -25% | -$46.2K | ﹤0.01% | 4530 |
|
|
2023
Q2 | $138K | Sell |
13,355
-71,515
| -84% | -$740K | ﹤0.01% | 4695 |
|
|
2023
Q1 | $784K | Buy |
+84,870
| New | +$784K | ﹤0.01% | 3128 |
|
|
2020
Q4 | – | Sell |
-21,738
| Closed | -$419K | – | 4429 |
|
|
2020
Q3 | $419K | Sell |
21,738
-528
| -2% | -$10.2K | ﹤0.01% | 2595 |
|
|
2020
Q2 | $582K | Buy |
22,266
+7,797
| +54% | +$204K | ﹤0.01% | 2388 |
|
|
2020
Q1 | $258K | Sell |
14,469
-17,250
| -54% | -$308K | ﹤0.01% | 2694 |
|
|
2019
Q4 | $1.06M | Buy |
+31,719
| New | +$1.06M | ﹤0.01% | 1522 |
|
|
2018
Q3 | – | Sell |
-4,563
| Closed | -$227K | – | 3935 |
|
|
2018
Q2 | $227K | Buy |
+4,563
| New | +$227K | ﹤0.01% | 2829 |
|